Clinical spectrum of fungal infections after orthotopic liver transplantation. 1991

P Castaldo, and R J Stratta, and R P Wood, and R S Markin, and K D Patil, and M S Shaefer, and A N Langnas, and E C Reed, and S J Li, and T J Pillen
Department of Surgery, University of Nebraska Medical Center, Omaha 68198-3280.

During a 50-month period, we identified 91 episodes of fungal infection in 72 liver transplant recipients (23.8%). Candida species accounted for 83.5% of cases. Clinical patterns of fungal infections included disseminated infection (19), peritonitis (17), pneumonitis (15), multiple sites of colonization (13), fungemia (11), and other sites (16). The diagnosis of fungal infection was usually made in the first 2 months (84.7% of cases), at a mean time of 16 days after transplantation. Risk factors for fungal infections included retransplantation, Risk score, intraoperative transfusion requirement, urgent status, Roux limb biliary reconstruction (in adults), steroid dose, bacterial infections and antibiotic therapy, and vascular complications. Fungal infections were successfully treated with amphotericin B in 63 cases (74.1%) but were associated with diminished patient survival (50% vs 83.5%). Fungal infection is a frequent source of early morbidity and can be related to well-defined risk factors, suggesting the need for effective prophylaxis.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009181 Mycoses Diseases caused by FUNGI. Fungus Diseases,Fungal Diseases,Fungal Infections,Fungus Infections,Disease, Fungal,Disease, Fungus,Diseases, Fungal,Diseases, Fungus,Fungal Disease,Fungal Infection,Fungus Disease,Fungus Infection,Infection, Fungal,Infection, Fungus,Infections, Fungal,Infections, Fungus
D002177 Candidiasis Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed) Candida Infection,Moniliasis,Candida Infections,Candidiases,Infection, Candida,Moniliases
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines

Related Publications

P Castaldo, and R J Stratta, and R P Wood, and R S Markin, and K D Patil, and M S Shaefer, and A N Langnas, and E C Reed, and S J Li, and T J Pillen
January 1995, Transactions of the American Clinical and Climatological Association,
P Castaldo, and R J Stratta, and R P Wood, and R S Markin, and K D Patil, and M S Shaefer, and A N Langnas, and E C Reed, and S J Li, and T J Pillen
December 2014, Journal of clinical and experimental hepatology,
P Castaldo, and R J Stratta, and R P Wood, and R S Markin, and K D Patil, and M S Shaefer, and A N Langnas, and E C Reed, and S J Li, and T J Pillen
February 1988, Transplantation proceedings,
P Castaldo, and R J Stratta, and R P Wood, and R S Markin, and K D Patil, and M S Shaefer, and A N Langnas, and E C Reed, and S J Li, and T J Pillen
September 1994, The Journal of infectious diseases,
P Castaldo, and R J Stratta, and R P Wood, and R S Markin, and K D Patil, and M S Shaefer, and A N Langnas, and E C Reed, and S J Li, and T J Pillen
October 1987, Transplantation proceedings,
P Castaldo, and R J Stratta, and R P Wood, and R S Markin, and K D Patil, and M S Shaefer, and A N Langnas, and E C Reed, and S J Li, and T J Pillen
June 1991, Transplantation proceedings,
P Castaldo, and R J Stratta, and R P Wood, and R S Markin, and K D Patil, and M S Shaefer, and A N Langnas, and E C Reed, and S J Li, and T J Pillen
April 2023, Journal of clinical medicine,
P Castaldo, and R J Stratta, and R P Wood, and R S Markin, and K D Patil, and M S Shaefer, and A N Langnas, and E C Reed, and S J Li, and T J Pillen
March 1998, Transplantation proceedings,
P Castaldo, and R J Stratta, and R P Wood, and R S Markin, and K D Patil, and M S Shaefer, and A N Langnas, and E C Reed, and S J Li, and T J Pillen
April 1991, HPB surgery : a world journal of hepatic, pancreatic and biliary surgery,
P Castaldo, and R J Stratta, and R P Wood, and R S Markin, and K D Patil, and M S Shaefer, and A N Langnas, and E C Reed, and S J Li, and T J Pillen
June 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
Copied contents to your clipboard!